These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 6720461)
41. Comparison of the subacute effects of a new glucocorticoid, deflazacort, and prednisone on the hypothalamic-pituitary-adrenal axis of normal subjects. Wajchenberg BL; Cesar FP; Luthold WW; Okada H; Borghi VC Braz J Med Biol Res; 1986; 19(1):39-47. PubMed ID: 3542091 [TBL] [Abstract][Full Text] [Related]
42. [Method for the comparative characterization of various steroids by their acute effect on Leukocytes and on endogenous cortisol secretion. Practical trial with a new steroid]. Schmid A; Studer H; Bucher HJ; Rohner R Schweiz Med Wochenschr; 1974 Mar; 104(9):316-22. PubMed ID: 4819673 [No Abstract] [Full Text] [Related]
43. Can 11β-hydroxysteroid dehydrogenase activity predict the sensitivity of bone to therapeutic glucocorticoids in inflammatory bowel disease? Cooper MS; Kriel H; Sayers A; Fraser WD; Williams AM; Stewart PM; Probert CS; Tobias JH Calcif Tissue Int; 2011 Sep; 89(3):246-51. PubMed ID: 21695543 [TBL] [Abstract][Full Text] [Related]
44. [Glucocorticoids and calcium metabolism regulation]. Babarykin DA Ter Arkh; 1984; 56(3):137-41. PubMed ID: 6372148 [No Abstract] [Full Text] [Related]
46. Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects. Paz-Pacheco E; Fuleihan GE; LeBoff MS J Bone Miner Res; 1995 Nov; 10(11):1713-8. PubMed ID: 8592948 [TBL] [Abstract][Full Text] [Related]
47. Are glucocorticoids harmful to bone in early rheumatoid arthritis? Lems WF Ann N Y Acad Sci; 2014 May; 1318():50-4. PubMed ID: 24739059 [TBL] [Abstract][Full Text] [Related]
48. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis. Messina OD; Barreira JC; Zanchetta JR; Maldonado-Cocco JA; Bogado CE; Sebastián ON; Flores D; Riopedre AM; Redondo G; Lázaro A J Rheumatol; 1992 Oct; 19(10):1520-6. PubMed ID: 1464862 [TBL] [Abstract][Full Text] [Related]
49. Effects of deflazacort on the renal handling of radiocalcium in man. Vattimo A; Loré F; Nuti R Adv Exp Med Biol; 1984; 171():399-405. PubMed ID: 6720463 [No Abstract] [Full Text] [Related]
51. Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate. Grecu EO; Weinshelbaum A; Simmons R Calcif Tissue Int; 1990 May; 46(5):294-9. PubMed ID: 2140069 [TBL] [Abstract][Full Text] [Related]
52. Adverse effects of corticosteroids on bone metabolism: a review. Mitra R PM R; 2011 May; 3(5):466-71; quiz 471. PubMed ID: 21570035 [TBL] [Abstract][Full Text] [Related]
53. Methods for reducing undesirable side effects of glucocorticoids. Hahn BH; Hahn TJ Adv Exp Med Biol; 1984; 171():301-11. PubMed ID: 6720461 [No Abstract] [Full Text] [Related]
54. Immunosuppressive effects of deflazacort - a new glucocorticoid with bone-sparing and carbohydrate-sparing properties: comparison with prednisone. Hahn BH; Pletscher LS; Muniain M J Rheumatol; 1981; 8(5):783-90. PubMed ID: 6458701 [TBL] [Abstract][Full Text] [Related]
55. Acute changes in urinary radiocalcium following glucocorticoids administration in man. Gennari C; Scala C; Imbimbo B; Bernini M; Montagnani M; Nardi P; Fusi L; Avioli LV Adv Exp Med Biol; 1984; 171():407-15. PubMed ID: 6372402 [No Abstract] [Full Text] [Related]
56. Effects of glucocorticoids and anabolic steroids on cells derived from human skeletal and articular tissues in vitro. Gallagher JA; Beresford JN; McGuire MK; Ebsworth NM; Meats JE; Gowen M; Elford P; Wright D; Poser J; Coulton LA Adv Exp Med Biol; 1984; 171():279-91. PubMed ID: 6720460 [No Abstract] [Full Text] [Related]